VERBATIM!
"I've heard that some manufacturers are developing low-cost CT scanners for cardiologists that will filter out all other data but cardiac. If a patient came to me complaining of chest pain, and I did a CT scan and found a lung tumor, and that patient told me that his cardiologist six months ago performed a CT scan with this special scanner that only imaged his coronaries and masked out the chest, I'd tell that patient to sue the cardiologist and the manufacturer of the scanner.
"I've heard that some manufacturers are developing low-cost CT scanners for cardiologists that will filter out all other data but cardiac. If a patient came to me complaining of chest pain, and I did a CT scan and found a lung tumor, and that patient told me that his cardiologist six months ago performed a CT scan with this special scanner that only imaged his coronaries and masked out the chest, I'd tell that patient to sue the cardiologist and the manufacturer of the scanner.
"To purposely mask out information after you radiate the patient to capture that data is unethical and opens up physicians to liability."
-Dr. David C. Levin, national medical director of HealthHelp, a utilization management company
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
